EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

From innovation network to public health benefit: evolutionary characteristics and optimization of the biomedical industry innovation network in the Beijing-Tianjin-Hebei region

Xinfei Xie, Mingmei Xiang, Qingli Tan

Frontiers in Public Health · 02.07.2026 · 14

DOI: 10.3389/fpubh.2026.1838874 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Public Health, online erschienen am 02.07.2026. Verfasst von Xinfei Xie und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Business, Guangdong Pharmaceutical University, Guangzhou, China. Hauptthemen laut MEDLINE: Public Health, Inventions, Biomedical Research. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science and Technology Planning Project of Guangdong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

As a core component of strategic emerging industries, the biomedical industry serves as a key indicator of regional scientific and technological innovation capacity and industrial competitiveness. The Beijing-Tianjin-Hebei (BTH) region possesses inherent advantages for development, including abundant research resources, a solid industrial foundation, and vast market potential. However, it also faces structural challenges such as insufficient collaboration within innovation networks and resource misallocation.

Methods

Based on multi-source data, including patent data and enterprise panel data from 2013 to 2023, this paper systematically analyzes the evolutionary characteristics of the BTH biomedical industry innovation network and identifies obstacles to its high-quality development. Methods such as social network analysis (SNA), the Temporal Exponential Random Graph Model (TERGM), and an obstacle degree model are employed.

Results

The study finds that the regional innovation network has evolved from a “dual-core monopoly” (2013–2018) to a “Beijing-Tianjin-Xiong'an triangle structure” emerging by 2023 forming a multi-level collaborative pattern. However, the main obstacles lie in the low efficiency of R&D personnel, insufficient conversion of patent revenue, and inadequate cross-regional policy coordination, with disconnections existing in the “R&D-conversion-industrialization” chain.

Discussion

To address these issues, this paper proposes strengthening the precise division of labor system: “Beijing for R&D, Tianjin for conversion, and Hebei for manufacturing” to improve full-chain innovation services to bridge conversion gaps, optimizing resource allocation to resolve mismatches, and implementing differentiated policies. From a public health perspective, these measures are designed to shorten the R&D-to-registration cycle, lower the cost of essential medicines, and reduce interregional health disparities. By accelerating the translation of biomedical innovations into accessible diagnostics, vaccines, and therapeutics, the optimized innovation network can directly enhance regional health security and epidemic response capacity. This aims to promote high-quality and coordinated regional industrial development, ultimately con tributing to improved public health outcomes by accelerating the translation of R&D into accessible diagnostics, vaccines, and therapeutics, and strengthening regional health security.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Public HealthInventionsBiomedical ResearchHumansChinaBeijingSocial Network Analysis

Stichwörter der Autor:innen

Beijing-Tianjin-Hebei regionTemporal Exponential Random Graph Model (TERGM)biomedical industryinnovation network evolutionobstacle factorspublic health translationregional health equitysocial network analysis (SNA)

Autor:innen und Institutionen

  • School of Pharmaceutical Business, Guangdong Pharmaceutical University, Guangzhou, China.

Förderung

  • Science and Technology Planning Project of Guangdong Province

Zitieren

APA

Xie, X., Xiang, M., & Tan, Q. (2026). From innovation network to public health benefit: evolutionary characteristics and optimization of the biomedical industry innovation network in the Beijing-Tianjin-Hebei region. Frontiers in Public Health, 14. https://doi.org/10.3389/fpubh.2026.1838874

Vancouver

Xie X, Xiang M, Tan Q. From innovation network to public health benefit: evolutionary characteristics and optimization of the biomedical industry innovation network in the Beijing-Tianjin-Hebei region. Frontiers in Public Health. 2026;14. doi:10.3389/fpubh.2026.1838874

BibTeX
@article{Xie2026,
  author = {Xie, Xinfei and Xiang, Mingmei and Tan, Qingli},
  title = {From innovation network to public health benefit: evolutionary characteristics and optimization of the biomedical industry innovation network in the Beijing-Tianjin-Hebei region},
  journal = {Frontiers in Public Health},
  year = {2026},
  volume = {14},
  doi = {10.3389/fpubh.2026.1838874}
}
Kostenlos starten →